Understanding Neuropathic Pain in Dogs

About 7–9% of dogs who arrive at a veterinary clinic with pain are thought to have neuropathic pain – pain coming from the nerves themselves, not from a visible wound or sore joint. In studies, these dogs often hurt for months or even years (1–60 months in one trial, with a median of 12 months) before anyone puts a name to what’s happening. That gap between “something is wrong” and “this is nerve pain” is exactly where many owners find themselves: a dog who yelps when lightly touched, licks or chews a leg that looks normal on X‑ray, or seems to be in pain even when resting.

This isn’t “mystery pain” or your imagination. It’s a very real, very physical process in your dog’s nervous system. Understanding it – even roughly – can turn confusion and guilt into a clearer sense of what questions to ask, what’s realistic to hope for, and how to live with a dog whose nerves have become too loud.

What exactly is neuropathic pain in dogs?

Neuropathic pain (often shortened to NeuP in research) is pain caused by damage or dysfunction of the somatosensory system – the network of nerves that carries information about touch, temperature, and pain to the spinal cord and brain.

It is not the same as:

• The sharp pain from stepping on glass

• The ache from arthritis

• The soreness after surgery

Those are mainly nociceptive pains: protective signals from injured tissues.

Neuropathic pain is what can follow when the wiring itself is injured or misbehaving.

Common conditions in dogs that can lead to neuropathic pain include:

• Intervertebral disc disease (IVDD) – slipped or herniated discs pressing on spinal nerves

• Spondylomyelopathies – diseases affecting the spinal cord and surrounding structures

• Lumbosacral syndromes – compression of nerves at the lumbosacral junction (lower back)

• Chiari‑like malformations – skull and brain malformations that crowd brain structures and spinal fluid pathways

• Nerve sheath tumors – tumors growing on or around nerves themselves

In these conditions, the original “injury” might be a disc, a bone change, or a tumor. But over time, the pain takes on a life of its own: the nerves and spinal cord become over‑sensitized, so pain continues – or even intensifies – long after the initial trigger should have settled.

Researchers describe neuropathic pain as a chronic, maladaptive pain state: pain that no longer protects the body, but instead becomes a disease process in its own right.

How neuropathic pain feels – in a body that can’t explain it

Dogs can’t say “it burns” or “it feels electric,” but human patients with neuropathic pain often use exactly those words. The same basic biology is at work in dogs, and the research gives us a vocabulary that helps make sense of what you’re seeing.

Key terms you’ll hear

• Allodynia: Pain from something that shouldn’t hurt. In a dog: yelping when you lightly stroke the back, pulling away when you gently brush a leg, reacting to a collar touch that used to be fine.

  
  

• Hyperalgesia: A stronger‑than‑normal response to something painful. In a dog: a mild pinch during an exam causes an outsized reaction; nail trimming becomes a battle when it wasn’t before.

  
  

• Sensitizing soup: A metaphor used by scientists for the mix of inflammatory and excitatory chemicals (like certain cytokines and neuropeptides) around an injured nerve. This “soup” keeps nerve endings irritated and lowers their threshold for firing, feeding into ongoing pain.

Over time, this constant firing changes how the spinal cord and brain process incoming signals. This is called central sensitization – the nervous system becomes “turned up,” so normal input is interpreted as a threat.

In dogs with neuropathic pain, studies show:

• Loss of normal inhibitory pain mechanisms (the brain’s built‑in brakes)

• Increased facilitatory responses (the accelerators on pain signaling)

• Altered responses on quantitative sensory testing (QST) – a research method that applies controlled stimuli (pressure, heat, cold) and measures when the dog reacts

So the dog’s behavior – flinching at a light touch, guarding a limb, restless at night – is the outward face of this altered wiring.

What’s happening inside: a calm tour of the biology

You do not need to memorize pathways to be a good caregiver. But a simple mental model can be surprisingly relieving: this is not “my dog being dramatic” or “me overreacting.” It is biology.

From injury to “stuck” pain

1. Peripheral nerve damage: A disc pushes on a nerve root, a tumor invades a nerve, or chronic compression slowly injures nerve fibers. Damaged nerves start firing abnormally – sometimes spontaneously, without any obvious trigger.

   
   

2. Inflammation at the injury site: The area around the nerve fills with that “sensitizing soup” – inflammatory mediators and excitatory chemicals. These make the nerve more irritable and easier to trigger.

   
   

3. Spinal cord changes (central sensitization): Repeated nerve firing sends a constant barrage of signals into the dorsal horn of the spinal cord (the main entry point for pain). There, neurons become more responsive, and inhibitory circuits weaken.

   Research in dogs and other species shows that pro‑inflammatory cytokines – especially TNF, IL‑1β, and IL‑6 – help maintain this sensitized state.

   
   

4. Brain processing shifts: The brain starts expecting pain, amplifying it, and linking it with mood and behavior. In humans, this is tied to anxiety, sleep disturbance, and depression. We can’t ask dogs about their mood, but we do see clinginess, irritability, or withdrawal.

The result: even if the original structural problem stabilizes, the pain can remain or flare with minimal provocation.

How common is neuropathic pain in dogs?

We don’t have perfect numbers, but the best estimates so far suggest:

• Around 7–9% of dogs presenting to veterinary clinics with pain likely have neuropathic pain as a component of their problem.

• In general emergency or critical care settings, more than 50% of dogs have some form of pain; neuropathic pain specifically still sits in that roughly 7–9% range.

In a controlled study of 29 dogs with naturally occurring neuropathic pain:

• Pain duration ranged from 1 to 60 months, with a median of 12 months.

• Many had spinal diseases like IVDD or lumbosacral disease.

So if your dog has had back, neck, or limb pain that never quite resolves, or behaviors that don’t match the X‑rays, neuropathic pain is not a far‑fetched idea – it’s a known pattern.

Why diagnosis is so hard (and not your fault)

There is no blood test, no simple “yes/no” scan for neuropathic pain in dogs. That uncertainty is hard on everyone: you, your dog, and your veterinarian.

What vets can use

Because dogs can’t self‑report, veterinarians rely on a combination of:

• History and behavior  

  • Sudden yelping or crying when touched lightly

  • Licking, chewing, or guarding a limb without obvious injury

  • Pain that seems worse at night or when resting

  • Changes in mood, sleep, or willingness to move

• Clinical pain scales  

  • Glasgow Composite Measure Pain Scale – Short Form (CMPS‑SF) and other structured tools to standardize how pain signs are scored in the clinic.

• Owner‑completed tools  

  • Canine Brief Pain Inventory (CBPI) – rates pain severity and impact on daily life

  • Client Specific Outcome Measures (CSOM) – tracks changes in tasks that matter for your dog (e.g., climbing stairs, jumping into the car)

• Imaging  

  • MRI or CT can reveal disc herniations, spinal cord compression, nerve sheath tumors, or Chiari‑like malformations.

  • But: the severity of what’s on the scan doesn’t always match the severity of pain. Some dogs with scary images cope well; others with modest changes are miserable.

• Quantitative Sensory Testing (QST)  

  • Used mainly in research so far, QST assesses how a dog responds to controlled stimuli (like gradually increasing pressure).

  • It can show patterns of hypersensitivity or loss of sensation, but it’s not yet standardized or widely available in everyday practice.

There are also human tools – like the Neuropathic Pain Scale (NPS) and Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) – that help distinguish neuropathic pain from other pain types. We don’t have direct equivalents for dogs because they rely on self‑description.

The caregiver placebo effect

In some studies, dogs given gabapentin (a common nerve‑pain medication) improved on pain scores – but dogs given placebo also improved more than expected. That doesn’t mean the pain was imaginary. It means:

• When we hope something will help, we may notice good days more and bad days less.

• We may interact differently with our dog when we believe treatment has started.

Researchers call this the caregiver placebo effect. It’s not a flaw in you as an owner; it’s a human reality. Vets who understand this use structured questionnaires and repeated assessments to get a clearer picture over time.

What treatment can look like: managing, not “curing”

Neuropathic pain is usually chronic. The goal is rarely to erase pain entirely; instead, it’s to:

• Reduce the intensity and frequency of pain

• Improve function (walking, sleeping, interacting, playing)

• Support a decent quality of life for both dog and human

Because the pain comes from a complex, sensitized nervous system, treatment is usually multimodal – several strategies layered together.

Common medications used for canine neuropathic pain

These are not instructions, just the landscape you might hear about in a veterinary consult.

• Gabapentin  

  • One of the most commonly used drugs for neuropathic pain in dogs.

  • Works on calcium channels in nerve cells, dampening abnormal firing.

  • Retrospective studies in 240 dogs suggest it is generally well tolerated and associated with improvements in pain scores (around 2.25 points on a visual analog scale).

  • Controlled trials show improvements in owner and vet scores, though sometimes not clearly superior to placebo – again reflecting the complexity of measuring pain.

• Pregabalin  

  • A close relative of gabapentin, sometimes used when gabapentin is insufficient.

  • May have different pharmacokinetics (how it’s absorbed and processed) and can be effective in some dogs.

• Amantadine  

  • An NMDA receptor antagonist that can help in central sensitization.

  • Often used as an adjunct rather than a stand‑alone treatment.

• Tricyclic antidepressants (TCAs) such as amitriptyline  

  • Modulate neurotransmitters involved in pain pathways.

  • Used off‑label, drawing on human neuropathic pain experience.

• Non‑steroidal anti‑inflammatory drugs (NSAIDs)  

  • Not neuropathic‑specific, but often part of the regimen when there is also inflammatory or orthopedic pain.

• Emerging and alternative options  

  • Macleaya extract and other botanical compounds are being explored as potential alternatives or complements to drugs like pregabalin, but evidence is still early and comparative effectiveness is under investigation.

Most dogs with neuropathic pain in real life are on multiple treatments: a gabapentinoid (gabapentin or pregabalin), possibly an NSAID, sometimes amantadine or a TCA, plus non‑drug therapies like physical rehabilitation.

Beyond pills: the rest of the toolkit

• Physical therapy and rehabilitation  

  • Gentle, targeted exercises to maintain muscle, improve stability, and reduce secondary strain.

  • Techniques like hydrotherapy can allow movement with less load on painful structures.

• Environmental adjustments  

  • Ramps instead of stairs, non‑slip flooring, supportive bedding, harnesses that avoid pressure on sensitive areas.

• Nutraceuticals and supplements  

  • Omega‑3 fatty acids, joint supplements, and others may be recommended, especially when neuropathic pain overlaps with arthritis or other conditions.

• Surgery  

  • In some cases (e.g., severe disc herniation or nerve sheath tumor), surgery addresses the underlying structural problem.

  • Even then, neuropathic pain may persist or develop, so post‑surgical pain management remains important.

Because many drugs used for neuropathic pain in dogs are off‑label and adapted from human medicine, there is an ethical tension: we’re using the best available evidence, but that evidence is still incomplete. Good vets are transparent about this, monitor closely, and adjust based on your dog’s actual response.

What is known vs. what’s still uncertain

It can help to see the landscape laid out clearly:

Aspect	Well‑established	Still uncertain / emerging
Mechanisms	Nerve injury leads to neuroinflammation and central sensitization; cytokines like TNF, IL‑1β, IL‑6 are involved.	Exact molecular targets and pathways specific to different breeds and diseases in dogs.
Causes	Commonly linked to spinal diseases, nerve tumors, and certain malformations.	True prevalence in the general dog population and in under‑studied conditions.
Gabapentin	Widely used; retrospective and anecdotal data support benefit for many dogs; generally well tolerated.	High‑quality, large, placebo‑controlled trials with unequivocal results.
Pain assessment	Owner questionnaires (CBPI, CSOM) and clinical scales (e.g., CMPS‑SF) are useful and widely used.	Standardized, objective tools like QST and biomarkers for everyday practice.
Emotional impact	Caregiver burden and placebo effects are real and significant.	Best strategies to systematically support owners’ mental health.
New therapies	Pregabalin and some botanical extracts (e.g., Macleaya) show promise.	Long‑term safety, comparative effectiveness, and which dogs benefit most.

This uncertainty is not a sign that your dog is a “mystery case.” It’s a reflection of a field still catching up to what owners and vets have been seeing for years.

The emotional reality: living with a dog whose nerves hurt

Owners of dogs with neuropathic pain often describe:

• Feeling guilty for missing earlier signs

• Feeling frustrated when tests are “normal” but the dog is clearly not

• Worry about over‑medicating versus fear of under‑treating pain

• Exhaustion from night‑time restlessness, frequent vet visits, and the mental load of chronic care

Veterinarians, on their side, juggle:

• The desire to relieve suffering with the limits of current science

• The emotional weight of supporting families through long, uncertain courses

• The difficulty of saying “I don’t know” when no single treatment works perfectly

None of this means your dog is beyond help. It does mean that success looks different than it might for a simple infection or injury.

Instead of “we fixed it,” success might look like:

• Fewer bad days

• Shorter, less intense flares

• Your dog sleeping more peacefully

• A return to some favorite activities, even if modified

That is real progress, even if it doesn’t feel dramatic.

Working with your veterinarian: questions and tools that help

Because neuropathic pain is complex and long‑term, the relationship with your veterinary team matters as much as any single drug.

Questions you might bring to an appointment

• “Given my dog’s history and imaging, could neuropathic pain be part of what we’re seeing?”

• “Would tools like the Canine Brief Pain Inventory or Client Specific Outcome Measures help us track changes over time?”

• “What signs should I watch for that suggest a medication is helping, and over what time frame?”

• “What side effects of these medications would you be most concerned about?”

• “How will we decide when to adjust the plan – and how often should we check in?”

• “Are there non‑drug approaches (physiotherapy, environment changes) that might make a meaningful difference for my dog?”

Tracking your dog’s pain at home

Because owner observations are central, it can help to:

• Keep a simple diary of:

  • Good vs. bad days

  • Specific activities that seem easier or harder

  • Any changes after medication adjustments

• Use consistent language: instead of “better/worse,” note things like “climbed the stairs without stopping” or “yelped when touched on the back twice today.”

This doesn’t just help your vet; it also protects you from the emotional whiplash of focusing only on the worst days.

The hardest question: quality of life and “how far do we go?”

Chronic neuropathic pain raises difficult ethical questions:

• How much ongoing discomfort is acceptable if there are also moments of joy?

• When is adding another medication helpful, and when is it just prolonging struggle?

• At what point does euthanasia become a compassionate choice rather than a failure?

There are no universal answers. What research and clinical experience do suggest is that:

• Quality of life is multidimensional: mobility, appetite, interest in people and environment, ability to rest, and freedom from constant distress all matter.

• Pain that is poorly controlled despite thoughtful, multimodal management may tip the balance.

• Honest, repeated conversations with your vet – where you can say what you’re actually seeing and feeling – are crucial.

If you reach a point where you’re asking these questions, it doesn’t mean you’ve done something wrong. It means you are taking your responsibility to your dog seriously.

A more grounded way to think about “what to do next”

If your dog yelps when touched, seems in pain without obvious injury, or has a chronic spinal or nerve condition, a realistic next step might look like this:

1. Name neuropathic pain as a possibility: Simply having the words “neuropathic pain” or “nerve pain” changes the conversation with your vet. It moves things from “mystery” to “hypothesis we can work with.”

   
   

2. Ask for a structured plan, not a miracle: That plan might include one or more medications, a timeline for reassessment, and specific behaviors to monitor.

   
   

3. Accept that trial and adjustment are part of the process: Because individual dogs vary and the evidence is still evolving, some trial‑and‑error is unavoidable. That’s not incompetence; it’s the nature of this condition.

   
   

4. Protect your own bandwidth: Chronic caregiving is demanding. It’s okay to ask:

   • “What is the simplest effective regimen we can try?”

   • “Can we space out rechecks to something I can manage?”

   • “Are there support resources for owners of chronically ill pets?”

     
     

5. Revisit goals over time: What you hope for at diagnosis (for example, full return to hiking) may shift to “comfortable neighborhood walks” or “content at home.” Adjusting goals is not giving up; it’s aligning with reality in a compassionate way.

Neuropathic pain in dogs lives in a strange space: often invisible on the surface, partly invisible even on scans, and yet deeply real in how it shapes a dog’s days. The science explains why this pain can persist, why it behaves oddly, and why it’s so hard to measure. It also explains why your observations matter so much.

You do not have to solve the biology. Your role is to notice, to advocate, and to stay in conversation – with your dog’s body, and with the people helping you care for it. When you understand that the flinch from a gentle touch or the restless pacing at night has a name and a mechanism, it becomes less of a personal failure and more of a shared problem to navigate.

And that shift – from “what am I missing?” to “this is nerve pain; here’s how we’ll approach it” – is often where both dogs and their humans start to find a little more ease.

References

1. KuKanich K, et al. Pain burden, sensory profile and inflammatory cytokines of dogs with naturally-occurring neuropathic pain. PLOS ONE. 2020.

2. Mathews KA. Neuropathic pain in veterinary patients, Part 1. DVM360. 2007.

3. Grubb T, et al. Managing Neuropathic Pain in Dogs. PubMed Central. 2016.

4. KuKanich K, et al. Pain burden, sensory profile and inflammatory cytokines of dogs. PubMed. 2020.

5. Mathews KA, et al. Comparative analysis of chronic neuropathic pain in companion animals. PubMed Central. 2008.

6. Lascelles BDX, et al. Retrospective Study of 240 Dogs Receiving Gabapentin for Chronic Pain. JSciMedCentral. 2020.

7. World Small Animal Veterinary Association (WSAVA). Neuropathic pain – Global Pain Council Guidelines. 2020.

8. [Author(s) not specified]. Macleaya Extract versus Pregabalin Therapeutic Effectiveness. Wiley Online Library. 2024.